| Literature DB >> 2206015 |
C Giraldi1, M C Masi, M Manetti, E Carabelli, A Martini.
Abstract
Reported here are the results of an open controlled study on the use of GM1 in cases of ischemic strokes in its acute phase. A statistically significant improvement was observed in cases treated with GM1 for neurological deficits (assessed by Mathew's rating scale, modified by Fritz-Werner) at 21, 60 and 120 days and for disability at 120 days.Entities:
Mesh：
Substances：
Year: 1990 PMID： 2206015
Source DB: PubMed Journal: Acta Neurol (Napoli) ISSN： 0001-6276